Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Buy
63
BRO Quote, Financials, Valuation and Earnings
Last price:
$113.31
Seasonality move
:
2.93%
Day range:
$111.47 - $112.61
52-week range:
$85.97 - $125.68
Dividend yield:
0.52%
P/E ratio:
31.32x
P/S ratio:
6.65x
P/B ratio:
4.73x
Volume:
1.9M
Avg. volume:
1.8M
1-year change:
25.14%
Market cap:
$32.2B
Revenue:
$4.7B
EPS (TTM):
$3.59
Analysts' Opinion
-
Consensus RatingBrown & Brown has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $118.51, Brown & Brown has an estimated upside of 5.39% from its current price of $112.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $102.00 representing 100% downside risk from its current price of $112.45.
Fair Value
-
According to the consensus of 10 analysts, Brown & Brown has 5.39% upside to fair value with a price target of $118.51 per share.
BRO vs. S&P 500
-
Over the past 5 trading days, Brown & Brown has overperformed the S&P 500 by 2.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Brown & Brown does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Brown & Brown has grown year-over-year revenues for 59 quarters straight. In the most recent quarter Brown & Brown reported revenues of $1.4B.
Earnings Growth
-
Brown & Brown has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Brown & Brown reported earnings per share of $1.15.
Enterprise value:
35.4B
EV / Invested capital:
3.32x
Price / LTM sales:
6.65x
EV / EBIT:
22.55x
EV / Revenue:
7.35x
PEG ratio (5yr expected):
2.99x
EV / Free cash flow:
27.48x
Price / Operating cash flow:
24.86x
Enterprise value / EBITDA:
19.63x
Gross Profit (TTM):
$2.4B
Return On Assets:
6.24%
Net Income Margin (TTM):
21.44%
Return On Equity:
16.34%
Return On Invested Capital:
10.16%
Operating Margin:
32.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.8B | $4.3B | $4.8B | $1.2B | $1.4B | |
| Gross Profit | $1.8B | $2.1B | $2.4B | $606M | $702M | |
| Operating Income | $1B | $1.2B | $1.4B | $391M | $452M | |
| EBITDA | $1.3B | $1.6B | $1.8B | $468M | $539M | |
| Diluted EPS | $2.42 | $3.25 | $3.59 | $1.02 | $1.15 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.8B | $4.3B | $4.4B | $5B | $5.9B | |
| Total Assets | $8.9B | $11.3B | $13.4B | $14.8B | $16.8B | |
| Current Liabilities | $2.2B | $2.4B | $3.8B | $4.9B | $4.9B | |
| Total Liabilities | $5.1B | $6.9B | $8.6B | $9B | $9.9B | |
| Total Equity | $3.8B | $4.3B | $4.8B | $5.8B | $6.8B | |
| Total Debt | $2.1B | $3.5B | $3.9B | $3.9B | $3.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $837.4M | $963M | $1.4B | $13M | $213M | |
| Cash From Investing | -$1.5B | -$632M | -$889M | -$88M | -$79M | |
| Cash From Financing | $306.6M | -$133M | -$215M | -$67M | -$218M | |
| Free Cash Flow | $783.4M | $893M | $1.3B | -- | $196M | |
BRO
Sector
Market Cap
$32.2B
$628.1M
Price % of 52-Week High
89.48%
87.3%
Dividend Yield
0.52%
1.97%
Shareholder Yield
0.56%
4.02%
1-Year Price Total Return
25.14%
9.14%
Beta (5-Year)
0.873
0.587
Dividend yield:
0.52%
Annualized payout:
$0.54
Payout ratio:
15.41%
Growth streak:
31 years
Technicals
8-day SMA
Buy
Level
$110.77
200-day SMA
Buy
Level
$108.72
Bollinger Bands (100)
Buy
Level
105.63 - 118.87
Chaikin Money Flow
Buy
Level
297.3M
20-day SMA
Buy
Level
$111.66
Relative Strength Index (RSI14)
Sell
Level
48.97
ADX Line
Sell
Level
34.14
Williams %R
Sell
Level
-8.4688
50-day SMA
Sell
Level
$116.19
MACD (12, 26)
Sell
Level
-1.34
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
207.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.644)
Sell
CA Score
(Annual)
Level (-0.535)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.1322)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The Company markets and sells insurance products and services, in the property, casualty, and employee benefits areas. It provides customers with non-investment insurance contracts, as well as other targeted, customized risk management products and services. It has four reportable segments; the Retail segment; the Programs segment; the Wholesale Brokerage segment and; the Services segment. It generates the majority of its revenue from the Retail segment which provides insurance products and services to commercial, public and quasi-public, and Others through automobile dealer services F&I businesses. Its geographic area is U.S., U.K., the Republic of Ireland, Canada, and Others.
Stock Forecast FAQ
In the current month, BRO has received 3 Buy ratings 7 Hold ratings, and 0 Sell ratings. The BRO average analyst price target in the past 3 months is $118.51.
-
Where Will Brown & Brown Stock Be In 1 Year?
According to analysts, the consensus estimate is that Brown & Brown share price will rise to $118.51 per share over the next 12 months.
-
What Do Analysts Say About Brown & Brown?
Analysts are divided on their view about Brown & Brown share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Brown & Brown is a Sell and believe this share price will drop from its current level to $102.00.
-
What Is Brown & Brown's Price Target?
The price target for Brown & Brown over the next 1-year time period is forecast to be $118.51 according to 10 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is BRO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Brown & Brown is a Hold. 7 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BRO?
You can purchase shares of Brown & Brown via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Brown & Brown shares.
-
What Is The Brown & Brown Share Price Today?
Brown & Brown was last trading at $113.31 per share. This represents the most recent stock quote for Brown & Brown. Yesterday, Brown & Brown closed at $112.45 per share.
-
How To Buy Brown & Brown Stock Online?
In order to purchase Brown & Brown stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 9.36% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is down 1.3% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 0.41% over the past day.
